SUPERNUS PHARMACEUTICALS INC (SUPN) Institutional Ownership and Insiders Activity
SUPERNUS PHARMACEUTICALS INC (SUPN) is widely held by institutional investors, with 324 firms reporting positions valued at approximately $2.81B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Blackrock, Inc. is the largest disclosed holder, reporting approximately $434.87M in SUPN holdings in its latest filing.
Recent insider activity includes 10 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
324
Total Reported Value
$2.81B
Largest Holder
Blackrock, Inc.
Largest Position
$434.87M
Insider Transactions (90d)
10
Latest Filing Quarter
Q2 2026
New Institutional Positions
50
Funds Exiting Positions
49
Top Institutional Owners
View allInvestorReported Balance
- Blackrock, Inc.$434.87M
- Millennium Management Llc$179.21M
- Vanguard Portfolio Management Llc$153.74M
- Armistice Capital, Llc$123.07M
- Vanguard Capital Management Llc$117.05M
SUPN News
All news- Ashford Capital Management Inc Q2 2026: Significant Purchases & Sales Observed
Aug 23, 2026 · valut.ai
Related SUPN Institutional Insights:
- SUPN 13F Institutional Holders
- SUPN Top Institutional Shareholders
- SUPN Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- SUPN Insider Trading & SEC Form 4 Activity
- SUPN Articles
- Top Institutional Investor Stock Rankings